Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

66.58 +5.60 (+9.18%)
Streaming Delayed Price Updated: 3:57 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
The Great Rotation: Small-Cap Stocks Surge in Early 2026 as Market Leadership Broadens
As of January 13, 2026, the financial landscape has undergone a dramatic transformation, marked by a decisive "regime shift" that many Wall Street analysts are calling the "Great Rotation." For the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019
As of mid-January 2026, the U.S. equity markets are witnessing a historic recalibration that few analysts predicted eighteen months ago. The Russell 2000 index, the benchmark for American small-cap... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Earnings Scheduled For October 28, 2025 ↗
 
Via Benzinga
News headline image
GeneDx Hldgs's Earnings: A Preview ↗
 
Via Benzinga
News headline image
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
From GeneDx
Via Business Wire
News headline image
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
From GeneDx
Via Business Wire
News headline image
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
From GeneDx
Via Business Wire
News headline image
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
From GeneDx
Via Business Wire
News headline image
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
From GeneDx
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
As the financial markets open for the 2026 calendar year, BTIG has released its highly anticipated "Top Picks" report for the first half of the year, signaling a transition from the speculative fervor... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
From GeneDx
Via Business Wire
News headline image
The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech
NEW YORK — In a dramatic shift that has redefined the market landscape of 2025, small-cap stocks have surged to historic levels, signaling what many analysts are calling the "Great Rotation." On... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025
As of mid-December 2025, the long-awaited "Great Rotation" in the financial markets has shifted from a theoretical prediction to a dominant reality. For the better part of the last three years,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
GeneDx Holdings Corp. (NASDAQ:WGS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗
GeneDx (WGS) stock passes a strict growth screen, combining Minervini's strong trend template with accelerating earnings and sales fundamentals. 
Via Chartmill
News headline image
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
From GeneDx
Via Business Wire
News headline image
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump ↗
The AI-powered genetic-testing company has been a strong performer. The CEO's recent move had more to do with accounting than conviction. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade ↗
The upgraded 74 RS Rating shows that the Chicago area-based home health care firm tops more than 70% of stocks for price performance. 
Via Investor's Business Daily
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout ↗
GeneDx (WGS) shows explosive earnings growth of 1,125% and strong technicals, presenting a high-growth momentum and breakout opportunity. 
Via Chartmill
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
The investment company displayed confidence in Teladoc's growth potential by expanding its holdings in the stock. 
Via The Motley Fool
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
 
Via Benzinga
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗
BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing ↗
Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
From GeneDx
Via Business Wire
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock ↗
GeneDx (WGS) stock aligns with growth & momentum strategies, showing a powerful uptrend backed by explosive earnings growth and strong technical health. 
Via Chartmill
News headline image
GeneDx to Participate in Upcoming Investor Conferences
From GeneDx
Via Business Wire
News headline image
What Does the Market Think About GeneDx Holdings Corp? ↗
 
Via Benzinga
News headline image
GeneDx (WGS) Q3 2025 Earnings Call Transcript ↗
GeneDx (WGS) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher ↗
GeneDx Q3 2025 earnings crush estimates with 52% revenue growth. Strong exome/genome test demand and raised 2025 guidance fuel investor optimism. 
Via Chartmill
Topics Earnings
News headline image
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
From GeneDx
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.